Repurposed Automated Handheld Counter as a Point-of-Care Tool to Identify Individuals ‘At Risk’ of Serious Post-Ivermectin Encephalopathy

PLoS Neglected Tropical Diseases

Volumn 8, Issue 9, 2014, Pages

  Bennuru, Sasisekhar ^a   Pion, Sébastien D S ^b,c   Kamgno, Joseph ^c,d   Wanji, Samuel ^e,f   Nutman, Thomas B ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c Center for Research on Filariasis and other Tropical Diseases   (Cameroon)

^d UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^e Research Foundation in Tropical Diseases and Environment   (Cameroon)

^f UNIVERSITY OF BUEA   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; SAPONIN; ANTIPARASITIC AGENT; MALONALDEHYDE;

ANIMAL EXPERIMENT; ARTICLE; BABOON; BLOOD EXAMINATION; BRAIN DISEASE; BRUGIA MALAYI; CAT; CELL COUNT; CELL COUNTER; CONTROLLED STUDY; DIROFILARIA IMMITIS; DOG; FIELD STUDY; HAND HELD AUTOMATED CELL COUNTER; HISTOGRAM; HUMAN; LOIASIS; LYMPHATIC FILARIASIS; MICROFILARIA; MICROFLUIDIC ANALYSIS; MICROSCOPY; NONHUMAN; ONCHOCERCIASIS; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; POINT OF CARE TESTING; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; ANIMAL; BLOOD; CAMEROON; CHEMICALLY INDUCED; COMPLICATION; HOSPITAL INFORMATION SYSTEM; LOA; MALE; PARASITOLOGY;

ANIMALS; ANTIPARASITIC AGENTS; BRAIN DISEASES; CAMEROON; CELL COUNT; HUMANS; IVERMECTIN; LOA; LOIASIS; MALE; MALONDIALDEHYDE; MICROFILARIA; PAPIO; POINT-OF-CARE SYSTEMS;

EID: 84907573409     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003180     Document Type: Article

References (17)

1. Mackenzie CD, Geary TG, Gerlach JA, (2003) Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients. Filaria J 2 Suppl 1S5.
2. Aziz MA, Diallo S, Diop IM, Lariviere M, Porta M, (1982) Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet 2: 171–173.
3. Boussinesq M, Chippaux JP, Ernould JC, Quillevere D, Prod'hon J, (1995) Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon. Am J Trop Med Hyg 53: 63–67.
4. Taylor HR, Greene BM, (1989) The status of ivermectin in the treatment of human onchocerciasis. Am J Trop Med Hyg 41: 460–466.
5. Chippaux JP, Boussinesq M, Gardon J, Gardon-Wendel N, Ernould JC, (1996) Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas. Parasitol Today 12: 448–450.
6. Ducorps M, Gardon-Wendel N, Ranque S, Ndong W, Boussinesq M, et al. (1995) [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin]. Bull Soc Pathol Exot 88: 105–112.
7. Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, et al. (1997) Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350: 18–22.
8. Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P, et al. (1998) Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. Am J Trop Med Hyg 58: 461–469.
9. Carme B, Boulesteix J, Boutes H, Puruehnce MF, (1991) Five cases of encephalitis during treatment of loiasis with diethylcarbamazine. Am J Trop Med Hyg 44: 684–690.
10. Boussinesq M, Gardon J, Kamgno J, Pion SD, Gardon-Wendel N, et al. (2001) Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon. Ann Trop Med Parasitol 95: 495–507.
11. Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux JP, (2003) Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J 2 Suppl 1S4.
12. Turner JD, Tendongfor N, Esum M, Johnston KL, Langley RS, et al. (2010) Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial. PLoS Negl Trop Dis 4: e660.
13. Bennuru S, Semnani R, Meng Z, Ribeiro JM, Veenstra TD, et al. (2009) Brugia malayi excreted/secreted proteins at the host/parasite interface: stage- and gender-specific proteomic profiling. PLoS Negl Trop Dis 3: e410.
14. Fink DL, Kamgno J, Nutman TB, (2011) Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia. PLoS Negl Trop Dis 5: e1299.
15. Drame PM, Fink DL, Kamgno J, Herrick JA, Nutman TB, (2014) Loop-mediated isothermal amplification for rapid and semiquantitative detection of Loa loa infection. J Clin Microbiol 52: 2071–2077.
16. Reid A (2012) Bringing the Lab to the Patient: Developing Point-Of-Care Diagnostics for Resource Limited Settings. American Academy of Microbiology. Available: http://academy.asm.org/index.php/clinical-medical-public-health-microbiology/526-bringing-the-lab-to-the-patient-developing-point-of-care-diagnostics-for-resource-limited-settings-2012. Accessed 20 August 2014.
17. Drain PK, Hyle EP, Noubary F, Freedberg KA, Wilson D, et al. (2014) Diagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis 14: 239–249.